plugin/skills/tooluniverse-disease-research/SKILL.md
Generate comprehensive disease research reports covering genetics (causal genes, GWAS, OMIM), pathways (Reactome, KEGG), drugs (existing therapies, repurposing candidates), clinical trials, epidemiology (prevalence, incidence), and phenotypes (HPO). Use for full disease overviews, comprehensive disease characterization, and orphan/rare-disease profiling.
npx skillsauth add mims-harvard/tooluniverse tooluniverse-disease-researchInstall this skill globally with one command. Works with Claude Code, Cursor, and Windsurf.
3 of 9 scanners reported clean
Some scanners were skipped, did not run, or reported a non-clean status. Review each row below.
Generate a comprehensive disease research report with full source citations. The report is created as a markdown file and progressively updated during research.
IMPORTANT: Always use English disease names and search terms in tool calls. Respond in the user's language.
When asked about a disease, query Orphanet/OMIM/DisGeNET FIRST. Don't rely on memory for prevalence, genetics, or treatment — these change over time. When you're not sure about a fact, your first instinct should be to SEARCH for it using tools, not to reason harder from memory.
DO NOT show the search process to the user. Instead:
{disease_name}_research_report.mdWhen synthesizing disease etiology, trace the full pathogenic cascade:
This chain structures the Genetic & Molecular Basis (Section 3) and Biological Pathways (Section 5) sections.
| Dim | Section | Key Tools | |-----|---------|-----------| | 1 | Identity & Classification | OSL_get_efo_id_by_disease_name, ols_search_efo_terms, ols_get_efo_term, umls_search_concepts, icd_search_codes, snomed_search_concepts | | 2 | Clinical Presentation | OpenTargets phenotypes, HPO lookup, MedlinePlus | | 3 | Genetic & Molecular Basis | OpenTargets targets, ClinVar variants, GWAS associations, gnomAD | | 4 | Treatment Landscape | OpenTargets drugs, clinical trials, GtoPdb | | 5 | Biological Pathways | Reactome pathways, humanbase_ppi_analysis, GTEx expression, HPA | | 6 | Epidemiology & Literature | PubMed, OpenAlex, Europe PMC, Semantic Scholar | | 7 | Similar Diseases | OpenTargets similar entities | | 8 | Cancer-Specific (if applicable) | CIViC genes/variants/therapies | | 9 | Pharmacology | GtoPdb targets/interactions/ligands | | 10 | Drug Safety | OpenTargets warnings, clinical trial AEs, FAERS |
See: tool_usage_details.md for complete tool calls per section.
Create this file structure at the start:
# Disease Research Report: {Disease Name}
**Report Generated**: {date}
**Disease Identifiers**: (to be filled)
---
## Executive Summary
(Brief 3-5 sentence overview - fill after all research complete)
---
## 1. Disease Identity & Classification
### Ontology Identifiers
| System | ID | Source |
### Synonyms & Alternative Names
### Disease Hierarchy
---
## 2. Clinical Presentation
### Phenotypes (HPO)
| HPO ID | Phenotype | Description | Source |
### Symptoms & Signs
### Diagnostic Criteria
---
## 3. Genetic & Molecular Basis
### Associated Genes
| Gene | Score | Ensembl ID | Evidence | Source |
### GWAS Associations
| SNP | P-value | Odds Ratio | Study | Source |
### Pathogenic Variants (ClinVar)
---
## 4. Treatment Landscape
### Approved Drugs
| Drug | ChEMBL ID | Mechanism | Phase | Target | Source |
### Clinical Trials
| NCT ID | Title | Phase | Status | Source |
---
## 5. Biological Pathways & Mechanisms
## 6. Epidemiology & Risk Factors
## 7. Literature & Research Activity
## 8. Similar Diseases & Comorbidities
## 9. Cancer-Specific Information (if applicable)
## 10. Drug Safety & Adverse Events
---
## References
### Tools Used
| # | Tool | Parameters | Section | Items Retrieved |
Every piece of data MUST include its source:
In tables: Add a Source column with tool name
In lists: - Finding [Source: tool_name]
In prose: (Source: tool_name, query: "...")
References section: Complete tool usage log with parameters
# After each dimension's research:
# 1. Read current report
# 2. Replace placeholder with formatted content
# 3. Write back immediately
# 4. Continue to next dimension
Every finding in the report should be graded:
| Grade | Criteria | Example | |-------|---------|---------| | T1 (Strong) | Replicated genetic evidence (GWAS, rare variants), FDA-approved therapy | BRCA1 → breast cancer; trastuzumab for HER2+ | | T2 (Moderate) | Single genetic study, phase II+ trial data, strong biological evidence | FOXO3 → longevity (centenarian studies) | | T3 (Association) | Observational data, gene expression changes, pathway membership | IL-6 elevated in Alzheimer's CSF | | T4 (Computational) | Network proximity, text mining, predicted associations | DisGeNET text-mined gene-disease link |
After collecting data from all 10 dimensions, the report MUST answer:
When multiple databases provide different data for the same disease:
| Conflict | Resolution | |----------|-----------| | Different prevalence estimates across sources | Report range; note the most recent/largest study | | Drug approved in one country but not another | Note regulatory status per region | | Gene-disease association in one DB but absent in another | Grade by evidence type; text-mining alone is T4 | | Clinical trial results contradict label indications | The trial result is newer evidence; note both |
For a well-studied disease (e.g., Alzheimer's), the final report should include:
Total: 500+ individual data points, each with source citation.
For rare disease differential diagnosis, run: python3 skills/tooluniverse-rare-disease-diagnosis/scripts/clinical_patterns.py --type differential --symptoms 'symptom1,symptom2'
tools
PCR / qPCR primer and oligo design — design forward/reverse primers for a target region (SantaLucia nearest-neighbor thermodynamics), compute melting temperature (Tm) and annealing temperature (Ta), check GC content, and screen an oligo for hairpins and primer-dimers. Use when you need primers for a sequence, want to QC an existing primer pair, or need the Tm of an oligo. Covers the primer-design rules (Tm matching, GC clamp, 3'-end, length) and the tools' constraint quirks.
tools
Pharmacokinetic (PK) analysis of concentration-time data — non-compartmental analysis (NCA) for Cmax, Tmax, AUC (0-t and 0-∞), terminal half-life, clearance (CL), volume of distribution (Vd), MRT, and absolute bioavailability (F). Also one-compartment fitting. Use when you have plasma/serum drug concentrations over time after a dose and need PK parameters, or to compute bioavailability from IV + oral AUCs. NOT for ADMET property prediction from structure (use tooluniverse-admet-prediction).
tools
Molecular cloning assembly design — Gibson Assembly (overlap design for seamless multi-fragment joining) and Golden Gate Assembly (Type IIS / BsaI / BbsI design with unique 4-bp fusion overhangs). Use when you need to plan how to join DNA fragments into a construct, design assembly overlaps/overhangs, or decide between cloning methods. Covers the domestication (internal-site removal), overhang-uniqueness, and overlap-Tm rules. For PCR primers to generate the fragments, see tooluniverse-primer-design.
tools
Meta-analysis / evidence synthesis — pool effect sizes across studies (odds ratios, risk ratios, hazard ratios, mean differences, correlations, GWAS betas) with fixed- or random-effects models, quantify heterogeneity (Q, I², τ²), and build a forest plot. Use when you have results from MULTIPLE studies and need a single pooled estimate, or to synthesize evidence from a systematic review / multiple GWAS / replicated experiments. Handles the error-prone effect-size + standard-error preparation (converting OR/HR/CI, two-group means±SD, proportions, and correlations into the (effect, SE) the pooling step needs).